Large-scale testing (Phase 3)UnknownNCT02174705What this trial is testingRotavirus vs. Sucrose for Vaccine Injection PainWho this might be right forVaccination Pain Management Anna Taddio 120
Large-scale testing (Phase 3)Study completedNCT00496054What this trial is testingSafety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)Who this might be right forGastroenteritisRotavirus Merck Sharp & Dohme LLC 110
Large-scale testing (Phase 3)Study completedNCT02193061What this trial is testingRandomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention ProgramsWho this might be right forRotavirus Vaccine National Institute of Pediatrics, Mexico 1,498
Post-approval studies (Phase 4)Study completedNCT02286895What this trial is testingImmune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in MaliWho this might be right forDiarrhea Rotavirus PATH 600
Not applicableStudy completedNCT01915888What this trial is testingStudy to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix VaccinationWho this might be right forInfections, Rotavirus GlaxoSmithKline 1
Not applicableStudy completedNCT00938327What this trial is testingReactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian InfantsWho this might be right forInfections, Rotavirus GlaxoSmithKline 332
Not applicableStudy completedNCT01026779What this trial is testingRotavirus Gastroenteritis and Vaccine Usage in Rhode IslandWho this might be right forRotavirus Gastroenteritis Lifespan 803
Large-scale testing (Phase 3)Study completedNCT02133690What this trial is testingA Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian InfantsWho this might be right forRotavirus Gastroenteritis Serum Institute of India Pvt. Ltd. 7,500
Large-scale testing (Phase 3)Study completedNCT02145000What this trial is testingEfficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in NigerWho this might be right forSevere Rotavirus Gastroenteritis Epicentre 6,586
Testing effectiveness (Phase 2)WithdrawnNCT01110044What this trial is testingStudy of a Birth Dose of GlaxoSmithKline Biologicals' 251154 VaccineWho this might be right forInfections, Rotavirus GlaxoSmithKline
Not applicableStudy completedNCT04123119What this trial is testingDevelopment of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge ModelWho this might be right forDiarrhoeal Disease Centre for Infectious Disease Research in Zambia 22
Testing effectiveness (Phase 2)Study completedNCT02109484What this trial is testingPhase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and InfantsWho this might be right forEvaluation of a Rotavirus Vaccine PATH 204
Not applicableStudy completedNCT01236066What this trial is testingImpact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in AustraliaWho this might be right forRotavirus GastroenteritisGastroenteritis GlaxoSmithKline 1
Large-scale testing (Phase 3)Study completedNCT00197210What this trial is testingTest 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy InfantsWho this might be right forInfections, Rotavirus GlaxoSmithKline 10,708
Not applicableStudy completedNCT02538211What this trial is testingThe Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune ResponsesWho this might be right forRotavirus InfectionsIntestinal Bacteria Flora DisturbanceReaction - Vaccine Nos+2 more Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 63
Large-scale testing (Phase 3)Study completedNCT01600092What this trial is testingThe Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)Who this might be right forRotavirus Gastroenteritis Merck Sharp & Dohme LLC 1,020
Testing effectiveness (Phase 2)Study completedNCT00385320What this trial is testingEvaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 MonthsWho this might be right forInfections, Rotavirus GlaxoSmithKline 2,640
Not applicableStudy completedNCT01733862What this trial is testingStudy to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus GastroenteritisWho this might be right forInfections, RotavirusRotavirus Vaccines GlaxoSmithKline 5,394
Testing effectiveness (Phase 2)Study completedNCT00346892What this trial is testingTo Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPVWho this might be right forRotavirus Infections GlaxoSmithKline 450
Testing effectiveness (Phase 2)Study completedNCT01377571What this trial is testingA Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy InfantsWho this might be right forDiarrheaFeverNausea+2 more National Institute of Hygiene and Epidemiology, Vietnam 200